Medicare Enrolled
Dr. Saman Lashkari, M.D.
Nephrology · Tarzana, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lashkari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lashkari?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lashkari
Dr. Saman Lashkari is a nephrology specialist in Tarzana, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lashkari performed 6,726 Medicare services across 3,610 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lashkari received a total of $11,615 from 78 pharmaceutical and/or device companies across 603 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lashkari is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in CA
$11,615 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,726
Medicare services
Top 7% in CA for nephrology
3,610
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~354 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,007 | $50 | $111 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
869 | $100 | $296 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
563 | $143 | $398 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
556 | $12 | $72 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
421 | $73 | $202 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
421 | $37 | $139 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
250 | $0 | $0 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
227 | $67 | $228 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
214 | $75 | $259 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
213 | $72 | $243 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
213 | $108 | $471 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
212 | $140 | $322 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
188 | $33 | $35 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
181 | $72 | $120 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
163 | $109 | $350 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
156 | $43 | $126 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
152 | $37 | $94 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
137 | $34 | $102 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
135 | $46 | $140 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
78 | $41 | $111 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
62 | $237 | $641 |
| Home visit, established patient, high complexity A home visit for an established patient involving high-level medical decision making, lasting at least 60 minutes. |
60 | $154 | $482 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
55 | $12 | $48 |
| Ear wax removal by washing This procedure involves the removal of impacted ear wax using a washing technique. |
41 | $11 | $61 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
32 | $16 | $72 |
| DTaP vaccine (ages 7+) A vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough) for individuals aged 7 years and older. |
32 | $26 | $100 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
30 | $104 | $348 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
17 | $178 | $473 |
| New patient office visit, complex (60-74 min) | 15 | $167 | $566 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
13 | $32 | $101 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
13 | $179 | $458 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,615
Total received (2018-2024)
Avg $1,659/year across 7 years
Top 10% in CA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
603
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,615 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,427
2023
$1,310
2022
$1,888
2021
$2,144
2020
$1,222
2019
$1,529
2018
$2,095
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$204
Otsuka America Pharmaceutical, Inc.
$134
Novo Nordisk Inc
$132
Novartis Pharmaceuticals Corporation
$129
Boehringer Ingelheim Pharmaceuticals, Inc.
$128
GlaxoSmithKline, LLC.
$91
Bayer Healthcare Pharmaceuticals Inc.
$69
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$62
PFIZER INC.
$49
Eisai Inc.
$49
CALLIDITAS THERAPEUTICS US INC.
$48
ABBVIE INC.
$48
Lilly USA, LLC
$47
AstraZeneca Pharmaceuticals LP
$46
Dexcom, Inc.
$31
Lundbeck LLC
$26
Phathom Pharmaceuticals, Inc.
$24
Sumitomo Pharma America, Inc.
$23
Xeris Pharmaceuticals, Inc.
$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$20
E.R. Squibb & Sons, L.L.C.
$19
Exact Sciences Corporation
$15
IDORSIA PHARMACEUTICALS US INC
$13
Top 3 companies account for 32.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,061
Novo Nordisk Inc
$1,029
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$806
Janssen Pharmaceuticals, Inc
$745
AstraZeneca Pharmaceuticals LP
$727
Boehringer Ingelheim Pharmaceuticals, Inc.
$572
Otsuka America Pharmaceutical, Inc.
$453
Lilly USA, LLC
$401
Novartis Pharmaceuticals Corporation
$333
PFIZER INC.
$273
GlaxoSmithKline, LLC.
$235
AbbVie Inc.
$233
Regeneron Healthcare Solutions, Inc.
$204
SANOFI-AVENTIS U.S. LLC
$191
ABBVIE INC.
$182
Bayer Healthcare Pharmaceuticals Inc.
$171
Bayer HealthCare Pharmaceuticals Inc.
$171
Horizon Therapeutics plc
$148
Allergan, Inc.
$143
Takeda Pharmaceuticals U.S.A., Inc.
$135
Amarin Pharma Inc.
$121
Astellas Pharma US Inc
$108
Merck Sharp & Dohme Corporation
$104
Alexion Pharmaceuticals, Inc.
$97
Biohaven Pharmaceutical Holding Company Ltd.
$77
MannKind Corporation
$73
Almatica Pharma LLC
$73
Radius Health, Inc.
$69
E.R. Squibb & Sons, L.L.C.
$68
IDORSIA PHARMACEUTICALS US INC
$68
Teva Pharmaceuticals USA, Inc.
$67
Allergan Inc.
$63
Lucid Diagnostics Inc.
$61
Bausch Health US, LLC
$60
Mallinckrodt LLC
$54
Dexcom, Inc.
$53
Sumitomo Pharma America, Inc.
$50
Eisai Inc.
$49
Mannkind Corporation
$48
CALLIDITAS THERAPEUTICS US INC.
$48
Horizon Pharma plc
$47
Alnylam Pharmaceuticals Inc.
$46
Abbott Laboratories
$46
Exact Sciences Corporation
$45
Genentech USA, Inc.
$45
Tactile Systems Technology Inc
$42
Noden Pharma USA Inc
$39
ARBOR PHARMACEUTICALS, INC.
$38
Mallinckrodt Hospital Products Inc.
$33
Mallinckrodt Enterprises LLC
$32
iRhythm Technologies, Inc.
$31
OPKO Pharmaceuticals, LLC
$29
Boston Scientific Corporation
$28
Mylan Specialty L.P.
$28
Linus Health, Inc.
$28
Lundbeck LLC
$26
Zyla Life Sciences
$26
Shield Therapeutics Inc
$24
Phathom Pharmaceuticals, Inc.
$24
GENZYME CORPORATION
$24
Xeris Pharmaceuticals, Inc.
$22
Avanir Pharmaceuticals, Inc.
$20
AbbVie, Inc.
$20
Philips Electronics North America Corporation
$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$20
Esperion Therapeutics, Inc.
$20
VIVUS, Inc.
$19
Merck Sharp & Dohme LLC
$19
Seqirus USA Inc
$19
NxStage Medical, Inc.
$18
Vertiflex, Inc.
$17
Axsome Therapeutics, Inc.
$16
Circassia Pharmaceuticals Inc
$16
IBSA Pharma Inc.
$14
Nabriva Therapeutics, plc
$14
Purdue Pharma L.P.
$14
Hikma Pharmaceuticals USA
$12
Advanced Respiratory, Inc
$12
Top 3 companies account for 33.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACCRUFER · ACTHAR · ADVAIR · AFREZZA · AJOVY · ANORO · APLENZIN · AREXVY · Aimovig · BASAGLAR · BENLYSTA · BEVESPI AEROSPHERE · BREZTRI · BYDUREON · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CORE COGNITIVE EVALUATION · Cologuard Collection Kit · DEXCOM G6 CGM SYSTEM · DUPIXENT · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EPOGEN · EVENITY · Edarbi · FARXIGA · FLEXITOUCH · FORTEO · FREESTYLE LIBRE 2 · Flexitouch Plus · Fluad Quadrivalent · GARDASIL 9 · GEMTESA · GVOKE HYPOPEN · INVOKANA · JANUVIA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LEQVIO · LICART · LINZESS · LOKELMA · LOREEV XR · LYRICA · Leqembi · Life 2000 Ventilation System · MOUNJARO · MYRBETRIQ · Mitigare · Myrbetriq · NEXLIZET · NUEDEXTA · NURTEC ODT · ONPATTRO · OPDIVO · Otezla · Ozempic · PNEUMOVAX 23 · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Parsabiv · Prolia · QSYMIA · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rayaldee · Repatha · Rybelsus · SAMSCA · SHINGRIX · SOLIRIS · SPRIX · SYMBICORT · SYMPROIC · Saxenda · Soliris · Sunosi · Superion ISS · Synthroid · System One · TARPEYO · TEKTURNA · TEZSPIRE · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Trintellix · Tymlos · UBRELVY · ULTOMIRIS · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Varithena Administration Pack · Vascepa · Victoza · WELLBUTRIN · Wegovy · X-MESH · XARELTO · XIFAXAN · XIFAXANIBSD · Xenleta · Xofluza · YUPELRI · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for nephrology in CA.
Geographic Context
Nephrologists within 10 mi
247
Per 100K population
2.5
County median income
$87,760
Nearest hospital
PROVIDENCE CEDARS SINAI TARZANA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lashkari is a clinical cardiology specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement in the top 10% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lashkari experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Lashkari performed 1,007 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lashkari receive payments from pharmaceutical companies?
Yes. Dr. Lashkari received a total of $11,615 from 78 companies across 603 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lashkari's costs compare to other nephrologists in Tarzana?
Dr. Lashkari's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lashkari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Tarzana
Browse nephrologists in Tarzana ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in CA
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in CA
Which CA nephrologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology